Filing Details
- Accession Number:
- 0001209191-15-081517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-20 16:08:27
- Reporting Period:
- 2015-11-18
- Filing Date:
- 2015-11-20
- Accepted Time:
- 2015-11-20 16:08:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-18 | 10,400 | $35.64 | 355,684 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-18 | 2,800 | $128.96 | 352,884 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-18 | 800 | $130.25 | 352,084 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-18 | 3,100 | $131.55 | 348,984 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-18 | 3,300 | $132.44 | 345,684 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-18 | 400 | $133.03 | 345,284 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-11-18 | 10,400 | $0.00 | 10,400 | $35.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
104,800 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,286 | Indirect | 401(k) |
Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $128.96 (range $128.71 to $129.52).
- Open market sales reported on this line occurred at a weighted average price of $130.25 (range $129.93 to $130.83).
- Open market sales reported on this line occurred at a weighted average price of $131.55 (range $130.94 to $131.89).
- Open market sales reported on this line occurred at a weighted average price of $132.44 (range $131.95 to $132.89).
- Open market sales reported on this line occurred at a weighted average price of $133.03 (range $132.96 to $133.07).
- Fully vested.